These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31928012)

  • 21. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
    Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
    BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
    Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
    EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathway-based biomarker search by high-throughput proteomics profiling of secretomes.
    Lawlor K; Nazarian A; Lacomis L; Tempst P; Villanueva J
    J Proteome Res; 2009 Mar; 8(3):1489-503. PubMed ID: 19199430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene.
    Wallrapp C; Müller-Pillasch F; Solinas-Toldo S; Lichter P; Friess H; Büchler M; Fink T; Adler G; Gress TM
    Cancer Res; 1997 Aug; 57(15):3135-9. PubMed ID: 9242439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signatures of protein expression revealed by secretome analyses of cancer associated fibroblasts and melanoma cell lines.
    Liberato T; Pessotti DS; Fukushima I; Kitano ES; Serrano SMT; Zelanis A
    J Proteomics; 2018 Mar; 174():1-8. PubMed ID: 29275043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma.
    Zheng X; Liu X; Zheng H; Wang H; Hong D
    Int Immunopharmacol; 2021 Jan; 90():106982. PubMed ID: 33129696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment.
    Lee YC; Gajdosik MS; Josic D; Clifton JG; Logothetis C; Yu-Lee LY; Gallick GE; Maity SN; Lin SH
    Mol Cell Proteomics; 2015 Mar; 14(3):471-83. PubMed ID: 25527621
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Deng Y; Ma H; Hao J; Xie Q; Zhao R
    Biomed Res Int; 2020; 2020():8604340. PubMed ID: 32420375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complementary RNA-Sequencing Based Transcriptomics and iTRAQ Proteomics Reveal the Mechanism of the Alleviation of Quinclorac Stress by Salicylic Acid in Oryza sativa ssp. japonica.
    Wang J; Islam F; Li L; Long M; Yang C; Jin X; Ali B; Mao B; Zhou W
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28906478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
    Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
    J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
    Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
    Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic profiling of the cancer cell secretome: informing clinical research.
    Hsiao YC; Chu LJ; Chen JT; Yeh TS; Yu JS
    Expert Rev Proteomics; 2017 Sep; 14(9):737-756. PubMed ID: 28695748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
    Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
    Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer secretome: finding out hidden messages in extracellular secretions.
    Padgaonkar M; Shendre S; Chatterjee P; Banerjee S
    Clin Transl Oncol; 2023 May; 25(5):1145-1155. PubMed ID: 36525229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Pancreatic Cancer Biomarkers eIF1, eIF2D, eIF3C and eIF6 Play a Major Role in Translational Control in Ductal Adenocarcinoma.
    Golob-Schwarzl N; Puchas P; Gogg-Kamerer M; Weichert W; Göppert B; Haybaeck J
    Anticancer Res; 2020 Jun; 40(6):3109-3118. PubMed ID: 32487605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of putative pancreatic cancer biomarkers using subcellular proteomics.
    McKinney KQ; Lee YY; Choi HS; Groseclose G; Iannitti DA; Martinie JB; Russo MW; Lundgren DH; Han DK; Bonkovsky HL; Hwang SI
    J Proteomics; 2011 Jan; 74(1):79-88. PubMed ID: 20807598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array.
    Vathipadiekal V; Wang V; Wei W; Waldron L; Drapkin R; Gillette M; Skates S; Birrer M
    Clin Cancer Res; 2015 Nov; 21(21):4960-9. PubMed ID: 25944803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative proteomics identified 3 oxidative phosphorylation genes with clinical prognostic significance in gastric cancer.
    Su F; Zhou FF; Zhang T; Wang DW; Zhao D; Hou XM; Feng MH
    J Cell Mol Med; 2020 Sep; 24(18):10842-10854. PubMed ID: 32757436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VHL-dependent alterations in the secretome of renal cell carcinoma: Association with immune cell response?
    Stehle F; Leisz S; Schulz K; Schwurack N; Weber N; Massa C; Kalich J; Fahldieck C; Seliger B
    Oncotarget; 2015 Dec; 6(41):43420-37. PubMed ID: 26486078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.